Telomerase is the enzyme that can add nucleotides back to telomeres, potentially extending cellular replicative lifespan
The products offered on this platform are not formulated, designed, or intended to diagnose, cure, mitigate, treat, or prevent any diseases or medical conditions
If more than 5 days have passed, skip the missed dose and resume your regular schedule
Visit our Shop today to discover the full range of offerings
Cardiovascular outcomes, long-term efficacy and safety In people with T2D and established cardiovascular disease, the international guidelines for T2D recommend the use of GLP-1 RA or sodium glucose co-transporters 2 inhibitors (SGLT-2i) as first-line treatment (independent of HbA1c), based on multiple trials demonstrating their cardio-renal benefits [109]
Potential off-target effects: broad changes to methylation could, in theory, affect gene expression in ways not yet characterised